Literature DB >> 23163407

Cardiac troponin I in congenital heart defects with pressure or volume overload.

Anneli Eerola1, Eero O Jokinen, Tanja I Savukoski, Kim S I Pettersson, Tuija Poutanen, Jaana I Pihkala.   

Abstract

OBJECTIVE: To evaluate the prevalence of cardiac troponin I (cTnI) and autoantibodies to cTn in children with congenital heart defects with volume or pressure overload fulfilling the criteria for treatment, and in healthy children.
DESIGN: The study groups comprised 78 children with volume overload caused by an atrial septal defect or a patent ductus arteriosus, and 60 children with pressure overload caused by coarctation of the aorta or stenosis of the aortic or the pulmonary valve, and 74 healthy controls. Serum levels of natriuretic peptides, cTnI, and autoantibodies to cTn were analyzed at baseline, prior to treatment and in 64 patients 6 months after treatment.
RESULTS: At baseline, one child with volume overload, 12 children with pressure overload, and one healthy control had positive cTnI. Further analysis of the pressure overload subgroup revealed that the children with positive cTnI were younger than those with negative cTnI, and had higher levels of natriuretic peptides. The pressure gradient at the coarctation site or stenotic valve was higher in those with positive TnI. Six months after treatment, 63 of 64 children examined were cTnI negative.
CONCLUSIONS: The cTnI release is more frequently associated with pressure than volume overload which resolves after treatment in most children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23163407     DOI: 10.3109/14017431.2012.751506

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  6 in total

Review 1.  Cardiac injury biomarkers in paediatric age: Are we there yet?

Authors:  Ana L Neves; Tiago Henriques-Coelho; Adelino Leite-Moreira; José C Areias
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

Review 2.  Cardiac biomarkers in children with congenital heart disease.

Authors:  Masaya Sugimoto; Seiko Kuwata; Clara Kurishima; Jeong Hye Kim; Yoich Iwamoto; Hideaki Senzaki
Journal:  World J Pediatr       Date:  2015-10-11       Impact factor: 2.764

3.  Detection of Early Myocardial Injury in Children with Ventricular Septal Defect Using Cardiac Troponin I and Two-Dimensional Speckle Tracking Echocardiography.

Authors:  Alyaa A Kotby; Manal M Abd Al Aziz; Adel H Husseiny; Marwa M Al-Fahham
Journal:  Pediatr Cardiol       Date:  2020-07-12       Impact factor: 1.655

4.  Sensitive Cardiac Troponins: Could They Be New Biomarkers in Pediatric Pulmonary Hypertension Due to Congenital Heart Disease?

Authors:  Seyma Kayali; Ilker Ertugrul; Tamer Yoldas; Ozkan Kaya; Senem Ozgür; Utku A Orün; Selmin Karademir
Journal:  Pediatr Cardiol       Date:  2018-01-16       Impact factor: 1.655

5.  Bedside biomarkers in pediatric cardio renal injuries in emergency.

Authors:  Noopur Singhal; Abhijeet Saha
Journal:  Int J Crit Illn Inj Sci       Date:  2014-07

6.  Prognostic value of troponin in infants with hypoplastic left heart syndrome between Stage I and II of palliation.

Authors:  Martin Christmann; Emanuela R Valsangiacomo Büchel; Hitendu Dave; Dietrich Klauwer; Anna Cavigelli-Brunner
Journal:  Ann Pediatr Cardiol       Date:  2018 Jan-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.